$0.349900
0.025.39%
At close: -
$0.332500
-0.02-4.97%
After Hours: 5:43 PM EDT
Comments
Loading...
IN8bio (NASDAQ:INAB) Stock Quotes, Forecast and News Summary
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy IN8bio (INAB) stock?
You can purchase shares of IN8bio (NASDAQ:INAB) through any online brokerage.
Who are IN8bio (INAB) competitors?
Other companies in IN8bio’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Curis (NASDAQ:CRIS), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT) and Geovax Labs (NASDAQ:GOVX).
What is the forecast, or price target, for IN8bio (INAB) stock?
IN8bio has a consensus price target of $8.00.
What is the current price for IN8bio (INAB)?
The stock price for IN8bio (NASDAQ: INAB) is $0.3325 last updated November 12, 2024 at 5:43 PM EST.
Does IN8bio (INAB) pay a dividend?
There are no upcoming dividends for IN8bio.
When is IN8bio (NASDAQ:INAB) reporting earnings?
IN8bio’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is IN8bio (INAB) going to split?
There is no upcoming split for IN8bio.
What sector and industry does IN8bio (INAB) operate in?
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.